Post Acute Care

2018 AHCA/NCAL Annual Convention

PAC-1 - An Introduction to Genomic Testing: Is This the Dawn of Personalized Medicine?

Monday, October 8
7:45 AM - 9:00 AM
CE: NAB: 1.25 | Nurses 1.25

Genomic testing represents an exciting advancement in developing individualized treatment plans for the post-acute patient, but navigating through the technology can be a complex and daunting process. Because this technology is still new, there are myriad questions to answer: What is the best technology? Does CMS pay for the testing? Does the technology cover all diagnoses? How are results communicated to patients and staff? The first part of this presentation will provide a high level historical background on the science of genomic testing, the current status of CMS approval for the testing (presently, this is limited to antipsychotics and pain meds, but CMS is actively studying adding other conditions), and a review of the payment models (because this has CMS approval, genomic testing is paid for by Medicare. Medicaid in most states, and managed care also pays for the test).

The second part of the presentation will discuss how one Post-Acute provider selected a genomic testing service (there are a LOT of companies out there who offer the service as an add-on, but only few who understand Post-Acute care), and will provide several case studies where genomic testing was used to help the treatment team make individualized medication recommendations (including reducing antipsychotic use). Case studies will also discuss how these changes lead to observable changes in patient behavior.

Learning Objectives:

Mark Pavlovich, MA

Sr. Director Analytics and Education
Southern Illinois University

Mark Pavlovich, MA, Sr. Director of Analytics & Education for CHSGa, a Georgia based health care system, and current Co-Chair of AHCA's Customer Experience Committee.

On the clinical side, Mark’s expertise includes working with children, adolescents, adults and seniors in special education, coma/neurological rehabilitation, dementia/mental wellness and care management.

On the operational side, Mark’s experience includes working with several internet startup companies, conducting merger and acquisition analysis, designing and applying integrated healthcare technology solutions for acute and post-acute health care providers in conceptual modeling, predictive and prescriptive analytics, and performance improvement programs.


Send Email for Mark Pavlovich

Allan A. Anderson, MD, MMM, CMD, DLFAPA

Assistant Professor of Psychiatry
Johns Hopkins School of Medicine

Allan A. Anderson, MD, MMM, CMD, DLFAPA

Dr. Allan Anderson is a board certified general and geriatric psychiatrist and is an Assistant Professor of Psychiatry at the Johns Hopkins University School of Medicine. He has expertise in psychopharmacology of mood disorders and treatment of dementia. He manages an outpatient psychiatric practice and also performs forensic psychiatric consultations.

He is a Distinguished Life Fellow of the American Psychiatric Association. He is a Certified Medical Director through the American Medical Director's Association. In 2015 he received a Masters of Medical Management from Carnegie Mellon University.

In the past he has served as President of the American Association for Geriatric Psychiatry and in 2014 was awarded Clinician of the Year by AAGP. He has presented locally, regionally, nationally, and internationally on various topics including the use of pharmacogenomic testing in selection of pharmacotherapy for psychiatric disorders.


Send Email for Allan Anderson


PAC-1 - An Introduction to Genomic Testing: Is This the Dawn of Personalized Medicine?

Audio Slides Handouts Video

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for An Introduction to Genomic Testing: Is This the Dawn of Personalized Medicine?